China grants emergency approval for its first Covid drug

By Agence France-Presse

Dec 09, 2021 3:50 pm

BEIJING: China's drug authority has granted emergency approval for the country's first specialized treatment against Covid-19, found in clinical trials to significantly reduce hospitalizations and deaths among high-risk patients.

The move comes as regulators around the world give the green light to treatments — particularly for high-risk groups — amid worries over the new Omicron variant.

This photo taken on December 8, 2021 shows a health worker collecting a sample from a visitor to be tested for the Covid-19 coronavirus at the World Intelligent Manufacturing Conference in Nanjing in China's eastern Jiangsu province. AFP PHOTO/ CHINA OUT

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Marcos confident administration senatorial bets to sweep 2025 polls

First Lady Liza Marcos to represent PH at Dubai's World Governments Summit

No winning bettor in Ultra, Megalotto draws for Jan 31

EDSA rally backs impeach-Sara call

PNP officer a victim of US air collision

4PS tops party-list poll, EduAksyon rises

Lawmakers pay tribute to Edcel Lagman